The increased risk of cardiovascular disease in people with HIV and specific strategies to treat it. This presentation discusses potential mechanisms, comorbidity gaps, and the impact of traditional risk factors. Explore the role of inflammation and immune dysfunction in atherosclerosis and vulnerab

0 views • 38 slides

This study explores how inflammation and cholesterol levels predict cardiovascular events among 13,970 statin-intolerant patients in the CLEAR Outcomes trial. Findings suggest residual inflammatory risk may be a stronger predictor than residual cholesterol risk for future events. The research analyz

0 views • 17 slides

Risk management in environmental geography and disaster management involves assessing the potential losses from hazards, evaluating vulnerability and exposure, and implementing strategies to mitigate risks. It includes calculating risk, dealing with risk through acceptance, avoidance, reduction, or

1 views • 10 slides

Cardiovascular disease is a growing concern in individuals living with HIV, despite advancements in treatment. The REPRIEVE Trial sheds light on the importance of assessing cardiovascular risk and implementing primary prevention measures in this population. Dr. Grinspoon's financial disclosures and

0 views • 35 slides

The natural history of disease development outlines the progression of a disease in an individual without intervention, from exposure to outcome. Learning objectives include defining prevention terms, understanding disease severity, prevention levels, and intervention measures. Studying disease prog

4 views • 16 slides

The REPRIEVE trial focuses on developing a cardiovascular disease prevention strategy for individuals living with HIV. It addresses the increased risk of CVD in this population, even with good viral suppression. The study evaluates the use of pitavastatin, a statin with anti-inflammatory properties,

1 views • 33 slides

Explore the differences between pediatric and adult cardiovascular exams, highlighting key differences in disease patterns, examination approaches, and objectives. Learn about the importance of distinguishing between routine well-baby exams and evaluations of ill children, along with step-by-step gu

5 views • 24 slides

Explore the comprehensive agenda covering topics like the general structure of the circulatory system, blood circulation in the human body, risk factors for cardiovascular diseases, and physiotherapeutic approaches in cardiac rehabilitation. Gain insights into the anatomy of the heart, arteries, vei

5 views • 14 slides

The CLEAR Outcomes Trial investigated the effects of bempedoic acid, an ATP citrate lyase inhibitor, on cardiovascular outcomes in primary prevention patients. Results showed a reduction in cardiovascular events with bempedoic acid, particularly in patients intolerant to statins. Baseline characteri

0 views • 13 slides

Cardiovascular disease (CVD) is a leading cause of maternal mortality in the US, with disparities in morbidity. Standardizing evaluation and triage is crucial. Preventability studies show a high potential for identifying at-risk cases. The CVD Toolkit aims to enhance awareness and readiness among he

1 views • 17 slides

Explore the significance of adopting a One Health approach to zoonotic disease risk assessment and communication in the context of emergency health situations. The session emphasizes core capacities required by the International Health Regulations (IHR) 2005, effective risk communication processes,

2 views • 13 slides

Exploring the immediate and long-term effects of exercise on the cardiovascular system reveals the remarkable adaptations and responses the body undergoes. From short-term increases in heart rate and blood pressure to long-lasting changes in cardiac output, exercise plays a crucial role in enhancing

0 views • 13 slides

This content discusses the DHA Risk Adjustment Model, its clinical conditions, and the utilization of risk scores in various populations. It outlines how Health Affairs sponsored the development of a tailored risk adjustment model for the Prime Population and provides examples of clinical conditions

0 views • 23 slides

Project risk management involves minimizing potential risks and maximizing opportunities through processes such as risk management planning, risk identification, qualitative and quantitative risk analysis, risk response planning, and risk monitoring and control. Quantitative risk analysis assesses t

0 views • 41 slides

The impact of diet on the cardiovascular system is significant, with a high intake of LDL leading to clogged arteries and increased risk of Coronary Heart Disease. Regular exercise brings about positive changes in the cardiovascular system, enhancing heart function and oxygen delivery. Immediate ben

0 views • 7 slides

In a secondary analysis of the CANTOS study, researchers evaluated the impact of residual inflammatory risk and residual cholesterol risk in a large cohort of atherosclerosis patients already receiving lipid-lowering therapy. Results showed the relative contributions of inflammation and cholesterol

0 views • 11 slides

This report discusses the morphologic and physiologic connections in continuous blood pressure waveforms and their association with incident cardiovascular events. The study aims to assess if changes in arterial elasticity contribute to predicting CVD events and explores additional measures derived

0 views • 30 slides

A cluster randomised controlled trial is being conducted to test an intervention aimed at reducing cardiovascular disease risk for individuals with severe mental illnesses in primary care settings. Led by Professor David Osborn at UCL Division of Psychiatry, the study is funded by the National Insti

0 views • 21 slides

Cardiovascular disease remains a significant contributor to maternal mortality in the UK, with maternal deaths from cardiac issues outnumbering those from other direct causes, except thrombosis. The prevalence of cardiovascular risk factors in pregnant women, combined with a lack of consideration fo

0 views • 22 slides

Patients with coronary artery disease should be screened for peripheral vascular disease as it is a frequent integrator of global cardiovascular risk. The association of atherosclerosis in various arterial diseases highlights the importance of identifying multisite artery disease. The prevalence and

0 views • 23 slides

The data report examines the prevalence of cardiovascular diseases in adult End-Stage Renal Disease (ESRD) patients in 2016 by treatment modality and age. It includes information on various cardiovascular conditions such as atrial fibrillation, acute myocardial infarction, coronary artery disease, a

2 views • 25 slides

The Human Disease Symptom Network (HSDN) is constructed using a large-scale medical bibliographic records database to form a network of human diseases based on symptom similarities. By integrating disease-gene associations and protein-protein interaction data, correlations between symptom similarity

0 views • 37 slides

This informative content discusses the normal physiological changes of the cardiovascular system in pregnancy, symptoms and signs of cardiovascular disease, the impact of pregnancy on cardiovascular health, and the management of cardiovascular issues during pregnancy, labor, and the postpartum perio

0 views • 28 slides

Explore the world of cardiovascular drugs, including antihypertensive, antianginal, heart failure, antiarrhythmic, diuretic, antithrombotic, and antihyperlipidemic medications. Dive into the mechanisms of action, clinical indications, and adverse effects of these drugs, gaining valuable insights int

0 views • 39 slides

Explore the essential concepts of risk in finance, such as risk definition, risk profiles, financial exposure, and types of financial risks. Learn about risk vs. reward trade-offs, identifying risk profiles, and tools to control financial risk. Understand the balance between risk and return, and the

0 views • 18 slides

This comprehensive presentation explores the intricacies of risk and return assessment in the realm of financial management. Delve into understanding risk concepts, measuring risk and return, major risk categories, and the impact of risk aversion on investment decisions. Gain insights into the manag

0 views • 62 slides

This session delves into the world of risk management and portfolio analysis at the programme/project level, specifically focusing on the Risk Management Unit of the United Nations Somalia. It covers enterprise risk management standards, planned risk management actions, the role of RMU, joint risk m

0 views • 30 slides

Study by Nicholas Marston, MD, and team shows that high-sensitivity cardiac troponin at any detectable concentration is linked to a higher risk of major cardiovascular events in patients with stable ischemic heart disease. The research, conducted through the PEGASUS-TIMI 54 trial, aimed to further u

0 views • 17 slides

Lipoprotein(a) levels play a crucial role in cardiovascular disease risk assessment, especially in patients undergoing statin therapy. This individual patient-data meta-analysis from the Lancet explores the predictive value of lipoprotein(a) levels in 29,069 patients across seven landmark statin tri

0 views • 10 slides

The study conducted by the PURE investigators examined the relationship between fruit, vegetable, and legume consumption and cardiovascular disease (CVD) and mortality in a cohort of 135,335 individuals from 18 countries. Dietary guidelines recommend at least 5 daily servings of these foods, which h

0 views • 27 slides

Anna, a 40-year-old housewife with a family history of cancer and diabetes, presents with elevated blood glucose levels, high cholesterol, and hypertension. Initial management includes lifestyle changes, medication for blood pressure and cholesterol, and smoking cessation. Follow-up visits show impr

0 views • 15 slides

Women's health encompasses the screening, diagnosis, and management of diseases and conditions affecting physical and emotional well-being. Services are provided by a diverse team of healthcare professionals specializing in obstetrics, gynecology, surgery, and primary care. Cardiovascular disease is

0 views • 46 slides

Excess body weight is a known risk factor for cancer, but not all obese individuals exhibit metabolic abnormalities. This study explores the concept of metabolically healthy obesity (MHO) and its association with cancer risk, aiming to understand the unique patterns of risk transmission compared to

0 views • 17 slides

Cardiovascular effects of older glucose-lowering therapies and the history of cardiovascular outcome trials are discussed in this educational slide module. It outlines the timeline of treatment options from the discovery of insulin to the introduction of various medications. Evidence regarding the c

0 views • 29 slides

Individuals with type 2 diabetes have an increased risk of cardiovascular events compared to those without the condition. Research indicates that certain GLP-1 receptor agonists have shown promising results in reducing cardiovascular events in diabetic patients with specific HbA1c levels. However, t

0 views • 69 slides

The ATLAS-ACS 2 study investigated the efficacy and safety of rivaroxaban in ACS patients post-index event. The primary endpoints included cardiovascular death, MI, and stroke, with significant reductions seen with rivaroxaban compared to placebo. Stent thrombosis was also reduced with rivaroxaban t

0 views • 10 slides

This study examines the association between ECG abnormalities and incident CVD events in patients with type 1 diabetes, focusing on the prognostic significance in a population where CVD develops earlier. Major and minor ECG abnormalities were classified, with cardiovascular events such as myocardial

0 views • 16 slides

Heart disease is a prevalent global issue, with cardiovascular diseases leading to millions of deaths annually. Lifestyle modifications, including dietary changes, play a crucial role in managing heart health. Despite being mostly preventable, cardiovascular disease remains a significant cause of mo

0 views • 16 slides

GripTrack is a portable grip strength monitoring device designed to track cardiovascular and musculoskeletal health in the elderly population. It aims to provide an accurate early warning system by assessing grip strength, which can indicate cognitive decline, cardiovascular health, and frailty synd

0 views • 14 slides

Heart disease, a prevalent health issue in the United States, encompasses various cardiovascular conditions like coronary artery disease and hypertension. It is a leading cause of death, often resulting from conditions that can lead to heart attacks or failure. Symptoms of heart conditions vary, fro

0 views • 28 slides